An Open Label, Randomised, Three-way Cross-over Study to Evaluate the Pharmacokinetics, Effect of Food, Safety and Tolerability of a New Tablet Formulation of GSK1144814 in Healthy Male and Female Subjects.
Latest Information Update: 06 Sep 2023
At a glance
- Drugs Elinzanetant (Primary)
- Indications Schizophrenia
- Focus Pharmacokinetics
- Sponsors GSK
Most Recent Events
- 23 Mar 2010 New trial record